Clinical Trial Update: A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of filgotinib in children and adolescents with Ulcerative Colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Ulcerative Colitis | Phase 3 | Status: RECRUITING